These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11520323)

  • 1. Long-term safety of tiagabine.
    Kälviäinen R
    Epilepsia; 2001; 42 Suppl 3():46-8. PubMed ID: 11520323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiagabine (gabitril) experience in children.
    Pellock JM
    Epilepsia; 2001; 42 Suppl 3():49-51. PubMed ID: 11520324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term safety of using tiagabine in epilepsy].
    Kozik A
    Neurol Neurochir Pol; 2000; 34 Suppl 7():17-22; discussion 22-3. PubMed ID: 11253488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiagabine: the safety landscape.
    Leppik IE
    Epilepsia; 1995; 36 Suppl 6():S10-S13. PubMed ID: 8595787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiagabine.
    Schachter SC
    Epilepsia; 1999; 40 Suppl 5():S17-22. PubMed ID: 10530690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiagabine: efficacy and safety in adjunctive treatment of partial seizures.
    Crawford P; Meinardi H; Brown S; Rentmeester TW; Pedersen B; Pedersen PC; Lassen LC
    Epilepsia; 2001 Apr; 42(4):531-8. PubMed ID: 11440349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tiagabine monotherapy on abilities, adjustment, and mood.
    Dodrill CB; Arnett JL; Shu V; Pixton GC; Lenz GT; Sommerville KW
    Epilepsia; 1998 Jan; 39(1):33-42. PubMed ID: 9578010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiagabine in clinical practice.
    Genton P; Guerrini R; Perucca E
    Epilepsia; 2001; 42 Suppl 3():42-5. PubMed ID: 11520322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the antiepileptic drug tiagabine.
    Schachter SC
    Clin Neuropharmacol; 1999; 22(6):312-7. PubMed ID: 10626090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons.
    Shinnar S; Berg AT; Treiman DM; Hauser WA; Hesdorffer DC; Sackellares JC; Leppik I; Sillanpaa M; Sommerville KW
    Epilepsia; 2001 Mar; 42(3):372-9. PubMed ID: 11442155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiagabine monotherapy in the treatment of partial epilepsy.
    Schachter SC
    Epilepsia; 1995; 36 Suppl 6():S2-S6. PubMed ID: 8595789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology and clinical experience with tiagabine.
    Schachter SC
    Expert Opin Pharmacother; 2001 Jan; 2(1):179-87. PubMed ID: 11336578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABI-balance--a non-interventional observational study on the effectiveness of tiagabine in add-on therapy in partial epilepsy.
    Chmielewska B; Stelmasiak Z
    Neurol Neurochir Pol; 2008; 42(4):303-11. PubMed ID: 18975234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of tiagabine: summary of 53 trials.
    Leppik IE; Gram L; Deaton R; Sommerville KW
    Epilepsy Res; 1999 Feb; 33(2-3):235-46. PubMed ID: 10094434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of controlled trials of gabitril (tiagabine): a clinician's viewpoint.
    Loiseau P
    Epilepsia; 1999; 40 Suppl 9():S14-9. PubMed ID: 10612357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of psychosis in patients with epilepsy randomized to tiagabine or placebo treatment.
    Sackellares JC; Krauss G; Sommerville KW; Deaton R
    Epilepsia; 2002 Apr; 43(4):394-8. PubMed ID: 11952769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient dystonias in three patients treated with tiagabine.
    Wolańczyk T; Grabowska-Grzyb A
    Epilepsia; 2001 Jul; 42(7):944-6. PubMed ID: 11488897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy.
    Adkins JC; Noble S
    Drugs; 1998 Mar; 55(3):437-60. PubMed ID: 9530548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring of renal function in epileptic children and teenagers treated with valproic acid or carbamazepine in concomitant therapy with tiagabine].
    Hurkacz M; Wiela-Hojeńska A; Orzechowska-Juzwenko K; Kozik A; Unolt J
    Pol Merkur Lekarski; 2001 Dec; 11(66):480-3. PubMed ID: 11899842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.